Biotie Therapies Corp.

Koko: px

Aloita esitys sivulta:

Download "Biotie Therapies Corp."

Markku Ville-Veikko Ahonen
7 vuotta sitten
Katselukertoja:

1 Biotie Therapies Corp. Timo Veromaa, President and CEO EGM

2 Future outlook 2006 (1/2) (As presented in the AGM 30 March 2006) Commercialize the European and Asian rights of nalmefene Bring the antibody program to the clinical development phase. BioTie is in discussions with new potential development partners to continue the recombinant heparin program.

antibody program to the clinical development phase.

3 Future outlook for 2006 (2/2) (As presented in the AGM 30 March 2006) BioTie s R&D spending during 2006 is expected to be somewhat lower compared to The company does not expect to receive milestone payments from agreements with Seikagaku Corporation and Somaxon Pharmaceuticals during The liquid resources are forecasted to be sufficient to finance the company s operations until the end of February 2007 BioTie is investigating different options to strengthen its financial position.

The company does not expect to receive milestone payments from agreements with Seikagaku Corporation and Somaxon

4 FINANCING The company has been investigating potential for fundraising involving international investors starting Q The target was to raise approximately 15 million euros International financing market down-turn Q2 2006

starting Q4 2005 The target was to raise approximately

5 EGM New Companies Act (Osakeyhtiölaki) entered into force September 2006 According to the new Act, the Finnish Accounting Standards (FAS; kirjanpitolaki) treatment of capital loans in balance sheet changed According to FAS, as of 30 September 2006, the equity (oma pääoma) of the company without taking into account the capital loans is less than one half of the share capital (osakepääoma) According to section 20, paragraph 23 of the Companies Act, the Board has to convene an EGM to resolve on measures

the equity (oma pääoma) of the company without taking into account the capital loans is less than one half of the share

6 Institutional offering Existing institutional owners expressed unwillingness to commit to significant further financing Aim to raise financing to fund company s operations for a minimum of 1,5 years Discussions with several institutional investors Pequot expressed serious interest to invest EUR 10 Million Pequot pre-condition that the Company s largest existing shareholders, or their order, shall subscribe for the new shares in the Offering at the value of three (3) million euro. Pursuant to this, the Company s shareholders, Thominvest Oy and Dreadnought Finance Oy gave an underwriting to subscribe shares so that the said companies and Sitra or entities nominated by them will subscribe for new shares at the aggregate subscription price which is at maximum EUR 3,000,000.

7 Shareholder offering Historically, limited interest from non-large investors in previous financing rounds in 2003 and % of existing owners declined to subscribe in the offering Other shareholders to be given the opportunity to participate in the offering with identical terms as the institutional investors

8 Use of proceeds Commercial partners expressed concern over sufficiency of company s working capital Revenue from commercial agreements alone not sufficient to safely fund the operations into next significant milestones

from commercial agreements alone not sufficient to

9 Laimennettu osakemäärä Osakkeita 52,675 miljoonaa Vaihtovelkakirjoja 1,278 miljoonaa Optio-oikeuksia 5,000 miljoonaa Yhteensä 58,953 miljoonaa Laskelmissa käytetty laimennettua osakemäärää Vaihtovelkakirjan optio-oikeuksien haltijoiden yhdenvertaisuus

miljoonaa Yhteensä 58,953 miljoonaa Laskelmissa käytetty

10 Osakeannin mitoitus Merkitsemällä jokaista kolmea omistamaansa osaketta kohtaan kaksi uutta, osakkeenomistaja säilyttää suhteellisen omistuksensa ennallaan Osakkeen keskikurssi kaupankäynnin määrällä painotettuna ajalla = 0,6328 euroa Keskikurssi vähennettynä 20%:lla -> Osakkeen merkintähinta on 0,51 euroa Uusien osak- Omistus ennen Omistus osake- keuden suhde osakeantia Osakeanti annin jälkeen vanhoihin Merkintätakauksen antaneet ja merkintäoikeudesta luopuneet tahot Muut osakkeenomistajat ,2 % Pequot Capital Yhteensä Omistusosuus ennen Omistusosuus osakeosakeantia Osakeanti annin jälkeen Merkintätakauksen antaneet ja 63,4 % 43,6 % merkintäoikeudesta luopuneet tahot Muut 36,6 % 36,6 % Pequot 0,0 % 19,8 % Yhteensä 100,0 % 100,0 %

2006 = 0,6328 euroa Keskikurssi vähennettynä 20%:lla -> Osakkeen merkintähinta on 0,51 euroa Uusien osak- Omistus ennen Omistus osake- keuden suhde osakeantia Osakeanti annin jälkeen vanhoihin

Samankaltaiset tiedostot

Wärtsilä Corporation. Interim Report January-September 2003 Ole Johansson President & CEO. 29 October Wärtsilä

Wärtsilä Corporation. Interim Report January-September 2003 Ole Johansson President & CEO. 29 October Wärtsilä Wärtsilä Corporation Interim Report January-September 2003 Ole Johansson President & CEO 29 October 2003 Highlights of the reporting period Order intake of Power Divisions increased. Clear improvement